Please login to the form below

Not currently logged in
Email:
Password:

Accelerated Access Review

This page shows the latest Accelerated Access Review news and features for those working in and with pharma, biotech and healthcare.

Ex-GSK head Witty to head group overseeing UK fast-track scheme

Ex-GSK head Witty to head group overseeing UK fast-track scheme

be selected for the Government’s new Accelerated Access Pathway (AAP), due to come into effect next April. ... Last October, the independent Accelerated Access Review (AAR) led by Sir High Taylor set out a series of recommendations for streamlining the

Latest news

  • NICE: We're the institute of 'yes' NICE: We're the institute of 'yes'

    The NHS is interested in managing access, not in blocking it," he said adding that NICE and pharma were "in the same business". ... The Strategy also made a series of recommendations that would overlap with and supplement the Accelerated Access Review,

  • Mixed news for pharma on UK's Accelerated Access Review Mixed news for pharma on UK's Accelerated Access Review

    Mixed news for pharma on UK's Accelerated Access Review. New funding will go towards ASHNs, SME’s and the Pathway Transformation Fund to name a few. ... The scheme is the first stage in the independent Accelerated Access Review (AAR) - designed to

  • NICE to bring HTA processes to mobile health apps NICE to bring HTA processes to mobile health apps

    Its evaluations will build on the Paperless 2020 simplified app assessment process - as recommended in the recent Accelerated Access Review - to create a “ digital infrastructure [that] should enable the system to ... The app is currently available on

  • UK to cut wait to innovative treatments by four years UK to cut wait to innovative treatments by four years

    UK to cut wait to innovative treatments by four years. Proposals in the Accelerated Access Review aim to speed up access to innovation. ... Published earlier this week, the 'Accelerated Access Review' sets out a series of recommendations for streamlining

  • UK pharma's contribution to NHS hits £1bn mark UK pharma's contribution to NHS hits £1bn mark

    We hope that the government's independent Accelerated Access Review … will provide an opportunity to address some of these issues.". ... At last count the review was scheduled for publication in April of this year.

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    Alongside this, rumours that NHS England was planning to include biosimilars on the Accelerated Access Pathway, the flagship policy intervention designed to speed up the use of innovative products, would amount ... Sciences Industrial Strategy and the

  • Working with our healthcare system more closely is vital Working with our healthcare system more closely is vital

    Take a recent local NHS partnership aimed at addressing specific access and capacity issues in Southampton. ... Specifically, this should include building on the recommendations put forward in the Life Science Industrial Strategy and the Accelerated

  • Macron, Merkel and May: implications of the 2017 elections for the life science industry Macron, Merkel and May: implications of the 2017 elections for the life science industry

    The ABPI has pursued legal action, arguing that this contravenes the NHS Constitution, which legally entitles patients access to NICE-approved treatments. ... Furthermore, the 2017 Conservative Party election manifesto promised to ‘implement the

  • Lighting the way Lighting the way

    Lighting the way. How the UK’ s Accelerated Access Review aims to guide medical innovations to their destination. ... She noted that engaging with the government on the new Life Sciences Strategy (see p7) and the Accelerated Access Review were among

  • Market access in Europe: balancing access and affordability Market access in Europe: balancing access and affordability

    In October 2016, the Accelerated Access Review (AAR) published its recommendations to the UK government. ... Furthermore, not all of these technologies would necessarily complete the Accelerated Access Pathway.

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics